Biotech Showcase: SX600 Presentation

SpineThera, a privately held, pre-clinical stage pharmaceutical company, announced that Jeff Missling, CEO, will give a company presentation at the BioTech Showcase in San Francisco, CA on Tuesday, 12 Jan 2016 at 4:15 pm. Missling said, "Meeting participants can expect to learn more about our patented micro-suspension, sustained-release corticosteroid technology at this presentation. Our lead product candidate, SX600, is a 505(b)2 drug in development for epidural administration. Physicians routinely administer epidural injections of relatively short-acting generic steroids to treat lumbosacral radiculopathy and other back pain conditions. We aim to develop improved drugs for this underserved market."

Presentation Details:

Parc 55 Hotel, 55 Cyril Magnin Street, San Francisco, California, USA, 94102

12 Jan 2016, 4:15 pm; Track E-Davidson (4ths Floor)

Attend BioTech 2016